Search Results - "Zidar, James P"

Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy by Patel, Kush P., Lansky, Alexandra J., Kereiakes, Dean J., Windecker, Stephan, Cristea, Ecaterina, Pietras, Cody, Dressler, Ovidiu, Issever, M. Ozgu, Curtis, Michael, Bertolet, Barry, Zidar, James P., Smits, Pieter C., Jiménez Díaz, Victor Alfonso, McLaurin, Brent, Brogno, David A., Janssens, Luc, Vrolix, Mathias C., Gómez-Blázquez, Iván, Sahul, Zakir H., Kabour, Ameer, Salido, Luisa, Cleman, Michael, Saito, Shigeru, Leon, Martin B., Baumbach, Andreas

“…The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be…”
Get full text

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus by Thomas, Alexander, Kereiakes, Dean J., Baumbach, Andreas, Windecker, Stephan, Pietras, Cody, Dressler, Ovidiu, Issever, M. Ozgu, Curtis, Michael, Bertolet, Barry, Zidar, James P., Smits, Pieter C., Jiménez Díaz, Victor Alfonso, McLaurin, Brent, Cequier, Ángel, Takahashi, Akihiko, Cannon, Louis A., Amoroso, Giovanni, Kakuta, Tsunekazu, Saito, Shigeru, Leon, Martin B., Lansky, Alexandra J.

“…Patients with diabetes mellitus (DM) have worse outcomes following percutaneous coronary intervention than nondiabetic patients. The novel Supreme DES is a…”
Get full text

Drug-Coated Balloons for In-Stent Restenosis by Kereiakes, Dean J., Kandzari, David E., Zidar, James P.

Get full text

Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial by Kandzari, David E, Weber, Michael A, Pathak, Atul, Zidar, James P, Saxena, Manish, David, Shukri W, Schmieder, Roland E, Janas, Adam J, Langer, Christopher, Persu, Alexandre, Mendelsohn, Farrell O, Ameloot, Koen, Foster, 3rd, Malcolm, Fischell, Tim A, Parise, Helen, Mahfoud, Felix

“…Renal denervation (RDN) has demonstrated clinically relevant reductions in blood pressure (BP) among individuals with uncontrolled hypertension despite…”
Get full text

Improving Patient Access to Medication: An ACC Chapter, Section Success Story by Stouffer, George A., Abernethy, William B., Zidar, James P., Wilson, B. Hadley

“…In return, the NCAFCC agreed to provide pre- and post-project implementation data on the following: 1) number of patients treated with clopidogrel; 2) number…”
Get full text

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial by Lansky, Alexandra J., Kereiakes, Dean J., Baumbach, Andreas, Windecker, Stephan, Hussain, Yasin, Pietras, Cody, Dressler, Ovidiu, Issever, Ozgu, Curtis, Michael, Bertolet, Barry, Zidar, James P., Smits, Pieter C., Alfonso Jiménez Díaz, Victor, McLaurin, Brent, Hofma, Sjoerd, Cequier, Ángel, Dib, Nabil, Benit, Edouard, Mathur, Anthony, Brogno, David, Berland, Jacques, Wykrzykowska, Joanna, Piegari, Guy, Brugaletta, Salvatore, Saito, Shigeru, Leon, Martin B.

“…Accelerated endothelial healing after targeted antiproliferative drug delivery may limit the long-term inflammatory response of drug-eluting stents (DESs). The…”
Get full text

The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel by Bangalore, Sripal, Bezerra, Hiram G, Rizik, David G, Armstrong, Ehrin J, Samuels, Bruce, Naidu, Srihari S, Grines, Cindy L, Foster, Malcolm T, Choi, James W, Bertolet, Barry D, Shah, Atman P, Torguson, Rebecca, Avula, Surendra B, Wang, John C, Zidar, James P, Maksoud, Aziz, Kalyanasundaram, Arun, Yakubov, Steven J, Chehab, Bassem M, Spaedy, Anthony J, Potluri, Srini P, Caputo, Ronald P, Kondur, Ashok, Merritt, Robert F, Kaki, Amir, Quesada, Ramon, Parikh, Manish A, Toma, Catalin, Matar, Fadi, DeGregorio, Joseph, Nicholson, William, Batchelor, Wayne, Gollapudi, Raghava, Korngold, Ethan, Sumar, Riyaz, Chrysant, George S, Li, Jun, Gordon, John B, Dave, Rajesh M, Attizzani, Guilherme F, Stys, Tom P, Gigliotti, Osvaldo S, Murphy, Bruce E, Ellis, Stephen G, Waksman, Ron

“…Significant progress has been made in the percutaneous coronary intervention technique from the days of balloon angioplasty to modern-day metallic drug-eluting…”
Get full text

Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study by Kereiakes, Dean J., Feldman, Robert L., Ijsselmuiden, A.J.J., Saito, Shigeru, Amoroso, Giovanni, Zidar, James P., Wong, S. Chiu, Stella, Pieter, Yakubov, Steven, Lasala, John, Cohen, David J., Doros, Gheorghe, Cutlip, Donald E., Rao, Sunil V.

“…Background: The SVELTE fixed-wire and rapid exchange bioresorbable-polymer sirolimus-eluting coronary stent systems (SVELTE sirolimus-eluting stent [SES]) are…”
Get full text

The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy by Hussain, Yasin, Saito, Shigeru, Curtis, Michael, Kereiakes, Dean J., Baumbach, Andreas, Zidar, James P., McLaurin, Brent, Dib, Nabil, Smits, Pieter C., Jiménez Díaz, Victor Alfonso, Cequier, Ángel, Hofma, Sjoerd H., Pietras, Cody, Dressler, Ovidiu, Issever, M. Ozgu, Windecker, Stephan, Leon, Martin B., Lansky, Alexandra J.

“…The PIONEER III trial demonstrated noninferiority of 12-month target lesion failure (TLF) with the Supreme DES (Sinomed), a thin-strut cobalt-chromium,…”
Get full text

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial by Cohen, David J, Bakhai, Ameet, Shi, Chunxue, Githiora, Louise, Lavelle, Tara, Berezin, Ronna H, Leon, Martin B, Moses, Jeffrey W, Carrozza, Jr, Joseph P, Zidar, James P, Kuntz, Richard E

“…Recently, sirolimus-eluting stents (SESs) have been shown to dramatically reduce the risk of angiographic and clinical restenosis compared with bare metal…”
Get full text

Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III by Garot, Philippe, Leon, Martin B., Saito, Shigeru, Baumbach, Andreas, Kereiakes, Dean J., Windecker, Stephan, Pietras, Cody, Dressler, Ovidiu, Issever, M. Ozgu, Curtis, Michael, Bertolet, Barry D., Zidar, James P., Smits, Pieter C., Jiménez Diaz, Victor Alfonso, McLaurin, Brent, Cequier, Angel R., Hofma, Sjoerd H., Dib, Nabil, Namiki, Atsuo, Takahashi, Akihiko, Kakuta, Tsunekazu, Hirohata, Atsushi, Lansky, Alexandra J.

“…The PIONEER III trial showed the 12-month safety and efficacy of the Supreme drug-eluting stent (DES) vs the durable polymer everolimus-eluting stent. We…”
Get full text

Final results of the can Routine Ultrasound Influence Stent Expansion (CRUISE) study by FITZGERALD, P. J, OSHIMA, A, MOSES, J. W, OESTERLE, S. N, OVERLIE, P. A, PEPINE, C. J, SAFIAN, R. D, SHANI, J, SIMONTON, C. A, SMALLING, R. W, TEIRSTEIN, P. S, ZIDAR, J. P, HAYASE, M, YEUNG, A. C, KUNTZ, R. E, YOCK, P. G, METZ, J. A, BAILEY, S. R, BAIM, D. S, CLEMAN, M. W, DEUTSCH, E, DIVER, D. J, LEON, M. B

“…Intravascular ultrasound (IVUS) can assess stent geometry more accurately than angiography. Several studies have demonstrated that the degree of stent…”
Get full text

The State of the Absorb Bioresorbable Scaffold by Bangalore, Sripal, Bezerra, Hiram G., Rizik, David G., Armstrong, Ehrin J., Samuels, Bruce, Naidu, Srihari S., Grines, Cindy L., Foster, Malcolm T., Choi, James W., Bertolet, Barry D., Shah, Atman P., Torguson, Rebecca, Avula, Surendra B., Wang, John C., Zidar, James P., Maksoud, Aziz, Kalyanasundaram, Arun, Yakubov, Steven J., Chehab, Bassem M., Spaedy, Anthony J., Potluri, Srini P., Caputo, Ronald P., Kondur, Ashok, Merritt, Robert F., Kaki, Amir, Quesada, Ramon, Parikh, Manish A., Toma, Catalin, Matar, Fadi, DeGregorio, Joseph, Nicholson, William, Batchelor, Wayne, Gollapudi, Raghava, Korngold, Ethan, Sumar, Riyaz, Chrysant, George S., Li, Jun, Gordon, John B., Dave, Rajesh M., Attizzani, Guilherme F., Stys, Tom P., Gigliotti, Osvaldo S., Murphy, Bruce E., Ellis, Stephen G., Waksman, Ron

“…Significant progress has been made in the percutaneous coronary intervention technique from the days of balloon angioplasty to modern-day metallic drug-eluting…”
Get full text

Randomized COMparison of platelet inhibition with abciximab, TiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: The COMPARE Trial by BATCHELOR, Wayne B, TOLLESON, Thaddeus R, OHMAN, E. Magnus, ZIDAR, James P, GRETLER, Daniel, DIBATTISTE, Peter M, TCHENG, James E, CALIFF, Robert M, HARRINGTON, Robert A, YAO HUANG, LARSEN, Rhonda L, MANTELL, R. Michael, DILLARD, Patricia, DAVIDIAN, Marie, DAOWEN ZHANG, CANTOR, Warren J, SKETCH, Michael H

“…Background— The relative anti-aggregatory effects of currently prescribed platelet glycoprotein IIb/IIIa receptor antagonists during and after percutaneous…”
Get full text

Clinical Conference Proceedings: 15th Biennial International Andreas Gruentzig Society Meeting by Anderson, H Vernon, Bersin, Robert M, Abbott, J Dawn, Aronow, Herbert D, Bass, Theodore A, Brilakis, Emmanouil S, Cavaye, Douglas M, Cohen, Mauricio G, Dean, Larry S, Dippel, Eric J, Garratt, Kirk N, Greenbaum, Adam B, Hanzel, George S, Helmy, Tarek, Lerman, Amir, Magd, Ayman A, Marshall, J Jeffrey, Medigo, Anthony, Mooney, Michael R, Naidu, Srihari S, O'Neill, Brian, Pichard, Augusto D, Rinaldi, Michael J, Sorajja, Paul, Szerlip, Molly A, Wood, David A, Zidar, James P

“…The International Andreas Gruentzig Society is an educational society of physicians and scientists interested in cardiovascular and related fields. Members…”
Get more information

Angiography and interventional cardiology by Zidar, James P

“…There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction…”
Get full text

Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III by Cohen, Marc, Diez, Jos E, Levine, Glenn N, Ferguson, 3rd, James J, Morrow, David A, Rao, Sunil V, Zidar, James P

“…This paper provides a comprehensive up-to-date review of the medical and invasive management of patients with non-ST-segment elevation acute coronary syndromes…”
Get more information

Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses by LANSKY, Alexandra J, ROUBIN, Gary S, MEHRAN, Roxana, KUNTZ, Richard E, LEON, Martin B, O'SHAUGHNESSY, Charles D, MOORE, Paul B, DEAN, Larry S, RAIZNER, Albert E, SAFIAN, Robert D, ZIDAR, James P, KERR, Jennifer L, POPMA, Jeffrey J

“…This prospective multicenter randomized clinical trial was designed to evaluate the long-term angiographic and clinical outcomes of elective treatment with the…”
Get full text

Comparison of Long-Term (Seven Year) Outcomes Among Patients Undergoing Percutaneous Coronary Revascularization With Versus Without Stenting by Kandzari, David E., Tuttle, Robert H., Zidar, James P., Jollis, James G.

“…Coronary stents have markedly improved the short- and intermediate-term safety and efficacy of percutaneous coronary intervention by improving acute gains in…”
Get full text

Low-molecular-weight heparins in coronary stenting (the ENTICES trial) by Zidar, JamesP

“…The role of low-molecular-weight heparins (LMWHs) in the management of stent thrombosis, although expected to produce fewer hemorrhagic complications than…”
Get full text